Steris
$208.54Change from previous close: −0.38%Absolute change: −$0.80
At a glance
- Revenue growth
- +8.73%
- FY to Mar 2026 vs FY to Mar 2025
- Net income growth
- +27.27%
- FY to Mar 2026 vs FY to Mar 2025
- Net margin
- 13.2%
- FY to Mar 2025: 11.3%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | 367 | 335 | 298 | 288 | 420 | — |
| Depreciation and amortization | 124 | 123 | 122 | 122 | 119 | — |
| Capital expenditure | -87.5 | -90.2 | -98.7 | -86.5 | -93.6 | — |
| Investing cash flow | -109 | -217 | -98.5 | -88.3 | -109 | — |
| Financing cash flow | -214 | -97.9 | -98.0 | -159 | -213 | — |
| Dividends paid | -61.4 | -61.8 | -61.9 | -61.9 | -56.2 | — |
| Share repurchases | -116 | -74.3 | -50.1 | -101 | -10.6 | — |
| Debt repaid | -37.8 | 34.8 | 0.0 | -4.3 | -156 | — |
| Effect of exchange rates | -2.3 | -4.4 | 2.9 | -0.9 | 9.6 | — |
| Net change in cash | 45.0 | 20.3 | 102 | 40.4 | 98.4 | — |
| Free cash flow | 280 | 245 | 200 | 201 | 326 | — |